These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11312015)

  • 1. Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccines.
    Bolgiano B; Mawas F; Yost SE; Crane DT; Lemercinier X; Corbel MJ
    Vaccine; 2001 Apr; 19(23-24):3189-200. PubMed ID: 11312015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccines.
    Otto RB; Crane DT; Bolgiano B
    Afr Health Sci; 2007 Dec; 7(4):190-6. PubMed ID: 21499483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccines.
    Ho MM; Lemercinier X; Bolgiano B; Crane D; Corbel MJ
    Biotechnol Appl Biochem; 2001 Apr; 33(2):91-8. PubMed ID: 11277861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant.
    Mariotti S; Teloni R; von Hunolstein C; Romagnoli G; Orefici G; Nisini R
    Vaccine; 2002 May; 20(17-18):2229-39. PubMed ID: 12009277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines.
    Ho MM; Mawas F; Bolgiano B; Lemercinier X; Crane DT; Huskisson R; Corbel MJ
    Vaccine; 2002 Oct; 20(29-30):3509-22. PubMed ID: 12297396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F; Newman G; Burns S; Corbel MJ
    J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.
    Rana R; Dalal J; Singh D; Kumar N; Hanif S; Joshi N; Chhikara MK
    Vaccine; 2015 May; 33(23):2646-54. PubMed ID: 25907408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among physico-chemical and biological tests for a synthetic Hib-TT conjugate vaccine.
    Cuervo ML; Pérez LR; Oviedo M; Costa L; Perdomo V
    Vaccine; 2007 Jan; 25(1):194-200. PubMed ID: 17161239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines.
    Siber GR; Anderson R; Habafy M; Gupta RK
    Vaccine; 1995 Apr; 13(6):525-31. PubMed ID: 7483772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability testing in Haemophilus influenzae type b conjugate vaccines.
    Klug B
    Dev Biol Stand; 1996; 87():263-7. PubMed ID: 8854026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
    Kamboj KK; King CL; Greenspan NS; Kirchner HL; Schreiber JR
    J Infect Dis; 2001 Oct; 184(7):931-5. PubMed ID: 11528593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical studies of the structure and stability of polysaccharide-protein conjugate vaccines.
    Jones C; Crane DT; Lemercinier X; Bolgiano B; Yost SE
    Dev Biol Stand; 1996; 87():143-51. PubMed ID: 8854011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines.
    Ho MM; Bolgiano B; Corbel MJ
    Vaccine; 2000 Nov; 19(7-8):716-25. PubMed ID: 11115692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
    Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines.
    Crowley-Luke A; Reddin K; Gorringe A; Hudson MJ; Robinson A
    Vaccine; 2001 May; 19(25-26):3399-407. PubMed ID: 11348704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine.
    An SJ; Woo JS; Chae MH; Kothari S; Carbis R
    Vaccine; 2015 Mar; 33(13):1614-9. PubMed ID: 25659268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine.
    Fusco PC; Michon F; Laude-Sharp M; Minetti CA; Huang CH; Heron I; Blake MS
    Vaccine; 1998 Nov; 16(19):1842-9. PubMed ID: 9795390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.